Messaging Therapy for Depression and Anxiety: A Longitudinal Effectiveness Study
- Conditions
- Anxiety DisordersDepressive Symptoms
- Registration Number
- NCT03699488
- Lead Sponsor
- Talkspace
- Brief Summary
Therapies delivered via technology have been developed to improve accessibility, however, there is limited research regarding messaging therapy in particular, and none that we know of utilizing a longitudinal effectiveness design. The aim of this study was to investigate the overall effectiveness of messaging therapy, identify any contributors to its effectiveness, and to evaluate a dosage effect for this type of treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12980
- Diagnosed Depression and/or Anxiety Disorder
- Any psychosis related symptoms or disorders
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change from Baseline in Anxiety symptoms on the Generalized Anxiety Disorder - 7 Up to 52 weeks Generalized Anxiety Disorder - 7 (GAD-7) is a measure of anxiety symptoms. It has 7 items, with a minimum of 0 and a maximum of 21, with higher scores indicating more symptoms and distress. Decreasing scores indicate better outcome. All items are summed to give the summary score.
Change from Baseline in Depressive symptoms on the Patient Health Questionnaire - 9 Up to 52 weeks Patient Health Questionnaire - 9 (PHQ-9) is a measure of depression symptoms. It has 9 items, with a minimum of 0 and a maximum of 27, with higher scores indicating more symptoms and distress. Decreasing scores indicate better outcome. All items are summed to give the summary score.
- Secondary Outcome Measures
Name Time Method Mean number of words sent from therapist to patient Up to 52 weeks Word counts of the words contained within messages sent
Mean number of words sent from patient to therapist Up to 52 weeks Word counts of the words contained within messages sent